By analyzing bulk RNA‐seq data of the tumor tissues collected before and after NIC (neoadjuvant immunochemotherapy) in patients with ESCC, the infiltration of CD8+ T cells and macrophages was assessed in responders and non‐responders of NIC therapy. This evidence concerns the gene CD8A and neoplasm.